يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"Drug Therapy, Combination/adverse effects"', وقت الاستعلام: 2.88s تنقيح النتائج
  1. 1

    المصدر: BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-14 (2020)
    Recercat: Dipósit de la Recerca de Catalunya
    Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    BMC Infectious Diseases
    Recercat. Dipósit de la Recerca de Catalunya
    instname

    وصف الملف: application/pdf

  2. 2

    المصدر: BASE-Bielefeld Academic Search Engine
    Dejgaard, T F, Johansen, N B, Frandsen, C S, Asmar, A, Tarnow, L, Knop, F K, Madsbad, S & Andersen, H U 2017, ' Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes ', Diabetes, Obesity and Metabolism Online, vol. 19, no. 5, pp. 734-738 . https://doi.org/10.1111/dom.12841

  3. 3

    المساهمون: AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), National Heart and Lung Institute [London] (NHLI), Imperial College London-Royal Brompton and Harefield NHS Foundation Trust, Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), Unité de Recherche Clinique de l’Est Parisien [CHU Saint-Antoine] (URC-EST), Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), McMaster University [Hamilton, Ontario], Stanford University, Uppsala University Hospital, AstraZeneca, Baim Institute for Clinical Research Boston MA, Medical University of Warsaw - Poland, Fudan University [Shanghai], Universidade de São Paulo (USP), Pontificia Universidad Católica de Chile (UC), Radboud University Medical Center [Nijmegen], University Hospital Kralovské Vinohrady, St. Michael's Hospital, University of Toronto, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Université de Montpellier (UM), Université Paris Diderot - Paris 7 (UPD7)-Université Paris 13 (UP13)-Institut National de la Santé et de la Recherche Médicale (INSERM), Royal Brompton and Harefield NHS Foundation Trust-Imperial College London, UCL - (MGD) Service de cardiologie, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire

    المصدر: The New England Journal of Medicine, 381, 1309-1320
    New England Journal of Medicine
    New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (14), pp.1309-1320. ⟨10.1056/NEJMoa1908077⟩
    Steg, P G, Bhatt, D L, Simon, T, Fox, K, Mehta, S R, Harrington, R A, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Leonsson-Zachrisson, M, Liu, Y, Opolski, G, Zateyshchikov, D, Ge, J, Nicolau, J C, Corbalán, R, Cornel, J H, Widimský, P, Leiter, L A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in Patients with Stable Coronary Disease and Diabetes ', The New England Journal of Medicine, vol. 381, no. 14, pp. 1309-1320 . https://doi.org/10.1056/NEJMoa1908077
    The New England Journal of Medicine, 381, 14, pp. 1309-1320
    The New England journal of medicine, Vol. 381, no. 14, p. 1309-1320 (2019)

    مصطلحات موضوعية: Male, Ticagrelor, THEMIS Steering Committee and Investigators, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], CLINICAL BENEFIT, Myocardial Infarction, Coronary Artery Disease, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, SECONDARY PREVENTION, Stroke/epidemiology, Coronary artery disease, 0302 clinical medicine, Hemorrhage/chemically induced, PRASUGREL, Medicine, 030212 general & internal medicine, Myocardial infarction, Stroke, 11 Medical and Health Sciences, Aspirin, Incidence, DUAL ANTIPLATELET THERAPY, Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6], General Medicine, 60 MG, Middle Aged, Clopidogrel, 3. Good health, Drug Therapy, Combination/adverse effects, Ticagrelor/adverse effects, Treatment Outcome, CLOPIDOGREL, Cardiology, Platelet aggregation inhibitor, PLATELET INHIBITION, Drug Therapy, Combination, Female, Life Sciences & Biomedicine, medicine.drug, Coronary Artery Disease/complications, medicine.medical_specialty, Platelet Aggregation Inhibitors/adverse effects, Hemorrhage, Aspirin/adverse effects, 03 medical and health sciences, Medicine, General & Internal, Double-Blind Method, Diabetes mellitus, Internal medicine, General & Internal Medicine, Myocardial Infarction/epidemiology, Humans, cardiovascular diseases, CARDIOVASCULAR EVENTS, Aged, Science & Technology, business.industry, Diabetes Mellitus, Type 2/complications, medicine.disease, MYOCARDIAL-INFARCTION, Diabetes Mellitus, Type 2, COLLABORATIVE METAANALYSIS, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Platelet Aggregation Inhibitors, Follow-Up Studies

  4. 4

    المساهمون: Public Health Sciences, RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation

    المصدر: Annals of the Rheumatic Diseases, 76(3), 511-520. BMJ Publishing Group

  5. 5

    المصدر: Neurology, 90(8), e683. Lippincott Williams and Wilkins
    Neurology

    وصف الملف: image/pdf

  6. 6
  7. 7
  8. 8

    المساهمون: Clinical sciences, Cardiology

    المصدر: Cannon, C P, Bhatt, D L, Oldgren, J, Lip, G Y H, Ellis, S G, Maeng, M, Merkely, B, Manassie, J, Januzzi, J L, Ten Berg, J M, Steg, P G, Hohnloser, S H & RE-DUAL PCI Steering Committee and Investigators 2017, ' Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation ', The New England Journal of Medicine, vol. 377, no. 16, pp. 1513-1524 . https://doi.org/10.1056/NEJMoa1708454

    وصف الملف: application/pdf

  9. 9

    المساهمون: Pharmaceutical and Pharmacological Sciences

    المصدر: RUC. Repositorio da Universidade da Coruña
    instname

  10. 10

    المساهمون: University of Zurich, Young, Jim

    المصدر: AIDS, Vol. 26, No 5 (2012) pp. 567-75